| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 93.615 | 97.437 | 109.107 | 123.581 | 137.193 | 136.898 | 152.552 | 174.370 | 188.720 |
| Total Income - EUR | - | 96.195 | 100.085 | 111.601 | 126.028 | 139.594 | 140.259 | 154.906 | 178.510 | 209.154 |
| Total Expenses - EUR | - | 84.441 | 96.340 | 105.544 | 114.400 | 119.756 | 130.944 | 136.973 | 165.303 | 156.707 |
| Gross Profit/Loss - EUR | - | 11.754 | 3.745 | 6.057 | 11.628 | 19.837 | 9.315 | 17.933 | 13.207 | 52.447 |
| Net Profit/Loss - EUR | - | 10.817 | 2.769 | 4.966 | 10.452 | 18.677 | 7.851 | 16.878 | 11.652 | 46.778 |
| Employees | - | 5 | 0 | 0 | 0 | 5 | 0 | 0 | 6 | 0 |
Check the financial reports for the company - Policlinica Narmedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 17.573 | 23.364 | 18.052 | 13.239 | 8.502 | 3.720 | 884 | 40 | 0 |
| Current Assets | - | 40.092 | 34.152 | 39.257 | 40.578 | 47.788 | 39.199 | 38.577 | 49.345 | 68.773 |
| Inventories | - | 11 | 14 | 10 | 0 | 0 | 36 | 0 | 0 | 0 |
| Receivables | - | 22.956 | 22.586 | 22.636 | 24.926 | 28.570 | 23.713 | 27.020 | 32.843 | 6.642 |
| Cash | - | 17.124 | 11.551 | 16.612 | 15.653 | 19.218 | 15.449 | 11.558 | 16.503 | 62.131 |
| Shareholders Funds | - | 32.538 | 34.756 | 39.084 | 38.881 | 42.933 | 32.346 | 20.476 | 11.850 | 46.826 |
| Social Capital | - | 45 | 44 | 43 | 0 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 25.165 | 7.397 | 5.629 | 5.021 | 6.020 | 5.736 | 16.480 | 37.535 | 21.947 |
| Income in Advance | - | 18.202 | 15.363 | 12.596 | 9.915 | 7.337 | 4.837 | 2.507 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Policlinica Narmedica Srl